Thursday, July 21, 2011

Oh My Aching Back: CEO Has Revolutionary LDS Surgery for L4L5 Pain

My guest blogger today is Paulo Yberri (pictured at left), who lives in San Ysidro California, and is the CEO of a large private hospital on the Baja Penninsula in Tijuana, just south of San Diego. His story is a lot like my husband's - ongoing back pain at the L4L5 that finally drove him to surgery.

My husband was cured of his pain, but only after FOUR surgeries in eight months. We have insurance, but the insurance company dropped us like a hot potato when the second surgery was required, citing a 'pre-existing condition' (meaning, the error the surgeon made in the first surgery).  The total bill: $165,000.  Yes, you read that right. Believe it or not, he never spent the night at the hospital.


By comparison, Paulo was in and out of the hospital in 24 hours, with a bill of $14,000, because he was lucky enough to work at a place where one of the world's leading back specialists, Dr. Juan Dipp, has written the global protocol for a new lumbar surgery made possible by US medical device manufacturer PercuDyn - a fairly common practice:

Medical Device Companies Look Abroad
Free Medical Webcast: Noninvasive LDS for L4L5: Free Your Back From Pain for Life

So without further ado, meet Paulo:  an active 37-year-old male: in addition to being a CEO of a large company, he practices martial arts and is a biker and skier, and the father of two young children.

"My first back injury occurred when I was in my late teens. I was never able to pinpoint one cause or event –I was very active at the time, and the injury was probably the result of a number of things, for example, at the time I was practicing jujitsu, being slammed into a mat all day long.

Being young , I didn’t pay much attention to the pain at first. I just figured it was a cramp, nothing I couldn’t handle. I have a fairly high tolerance for pain, and this exacerbated the problem. My back began to get very painful, but only sporadically. If I laid down or stretched, it would feel better. The pain didn’t disappear, but it was manageable, so I kept on ignoring it.

Soon I was living with and managing the pain on a daily basis. I became aware that I was almost never pain free. I didn’t want to face the reality that something could be wrong with my back in a permanent way. But after awhile, the pain went from uncomfortable to totally unbearable. In the last two years it was a constant drag on my life: the pain was always there, and I was always aware of it.

You’d think that as a hospital director I of all people would understand that untreated pain does not go away by itself. But like many men, I though I could stand it ….that is, until the pain finally became so bad that I could not move easily, or get out of my chair like normal. My activities were limited by the pain; I could no longer work out with any intensity.
"At age 35 I was about to become a dad for the first time..but I was moving like a granddad."
 
The breaking point was when I had to start taking shots and medication on a regular basis, just to deal with the pain. I finally faced the fact that my back was not only not going to fix itself, it was degenerating, and I began to search for options.

Because I am a hospital director I was able to get access to many physicians to discuss treatments. I discussed spinal fusion with a very prominent surgeon in California, and while I am sure he would have done a great job, but I didn’t think it was a good option. Spinal fusion is an expensive surgery, a two-level fusion that results in a loss of mobility, a long recuperation time, and there is only a 70% chance of being pain free afterward. To me, the cost benefit analysis simply did not bear out.

When Dr. Dipp told me he was setting up protocols for a new spinal procedure that he was very optimistic about called Lumbar Dynamic Stabilization, I became very interested. I liked that it was low invasive, ambulatory and reversible…in short, very low risk with a very high likelihood of success. I would not require general anesthesia and there would be no risk of loss of mobility. I particularly liked that recovery time for LDS is lower than any other alternative out there, and that the procedure is reversible.

“The cost benefit analysis of spinal fusion, with its long recuperation and only a 70% success rate, did not bear out.”
In the ER, they sedated me but not full anesthesia. The surgery took 32 minutes. I woke up in recovery, went to my room, and was able to walk to the bed on my own. My only pain was a slight soreness from the incision. The next day I was walking around with no need for medication.

Today my life is exactly as it was before the back pain entered. Everything is normal –my sex life, my athletic life, everything is as it should be for a healthy 35 year old man. In the end, I suffered too much pain by not dealing with the problem, but I was very very lucky that when I was ready to deal with it, I did not have to take a risky and expensive measure like spinal fusion, that this innovative LDS procedure was available to me.

I’m proud that a surgeon on our hospital staff is working with PercuDyn (the American manufacturer of the implant device) to develop the worldwide protocol for this procedure –meaning, he is training surgeons around the globe in LDS. The LDS procedure is only available in Mexico and Europe, it is still in the clinical trial stage in the U.S.

Of course, we work with medical travelers every day at Hospital Angeles Tijuana –everything from coronary bypass to cataract surgery. Any US patient who is like me -unhappy with the high price tag, long recovery and 70% confidence of spinal fusion (especially in the US) can come to Hospital Angeles Tijuana to have the procedure with Dr. Dipp. We’re just a few minutes away from San Diego and we handle everything for the patient, including their travel itinerary.

Thanks for Paulo for sharing his story! If you are interested in learning more about the LDS procedure, contact a Health Travel Guide toll free at 866.978.2573 or go online to chat.

Monday, July 18, 2011

Surprising Science in Fido's Fat:


You read it here first: liposuction for dogs is real, it's out there, and it's happening now.  But far from being a procedure for the canine captives of Paris Hilton, 'puppy liposuction' is a tool for an actual scientific breakthrough - stem cell therapy for dogs provided by, among others, VetStem.  

Vet-Stem, formed in 2002, provides stem cell therapy for dogs as well as horses, most notable Be A Bono, who raced to more than $1 million in prizewinnings after stem cell treatment for a potentially career-ending injury.


If you are one of those who consider stem cell therapy an ostentatious display of spending for a mere pet, the price tag vis a vis contentional medicine might suprise you.  Take the example of the Riha family, whose story appeared on ABC News. When the Riha's beloved golden retriever Hunter was suffering from arthritis so severe he could no longer stand, the Riha's had the choice of a $10,000 doggy hip replacement, or $2,500 for a stem cell transplant. 

Hunter's procedure was simple: first he underwent 'puppy lipo'; the extracted adipose (fat) tissue is the source of the autologous (i.e. self-donated) stem cells, which were then isolated and expanded in the laboratory.  The remaining stem cells  - now in much greater concentration than Hunter's body could accomplish on its own - were then reinjected into the dog's hip. 

Hunter is one of thousands of dogs who have been treated successfully with stem cells; some pet owners are so sold on the treatment they have commissioned it more than once, for example New Yorker Julia Szabo, a fashion editor who was so impresed with the boost in quality of life her dog Sam had in the years after his treatment, she was quick to sign a second pet up fro the treatment when hip dysplasia severely limited his mobility.

  • Listen to an interview with Julia Szabo about her pet stem cell treatments on MedicalTravelTalk 
  • Julia Szabo on the Today show here


Not Ready for Prime Time: Stem Cells For Humans?
Just as research in the adult autologous stem cell treatment arena ha proliferated (there are currently more than 50,000 adult stem cell papers registered at the libraries of the National Institutes of Health), so too has the commercialization of stem cell treatment undergone a similar explosion. 


While a few companies in the United States have  begun clinical trials with stem cells derived from the adipose tissue of humans, treatments are available for a number of orthopedic, cardiac and neurodegenerative disease conditions, among others, for the intrepid patient willing to travel abroad.


Conditions treated with adult stem cells include Chronic Obstructive Pulmonary Disease (COPD), Multiple Sclerosis (MS), Alzheimer's, and even breast regrowth after mastectomy.   Although there are no protocols specifically treating stroke, like my dear friend Annie had, this treatment is undoubtedly awaiting us in the future.


In the United States, medical device manufacturer BioHeart has identified the first of six planned Stem Cell Centers of Excellence at Hospital Angeles in Tijuana.  In a press release, BioHeart's President and CEO Mike Tomas stated,


"We are extremely excited about the Center of Excellence established (at Hospital Angeles) in Mexico...and the preliminary results are very promising.  We look forward to providing novel therapies and regenerative medicine to additional heart failure patients whose options are currently limited."

Major League baseball pitcher Bartolo Colon had his now famous stem cell treatment in the Dominican Republic through a doctor associated with the Yankees (see: Athletes and Stem Cells: Miracle Fountain of Youth or Banned Performance Enhancer?).  However, stem cell therapy is not only for dogs, horses and the rich and famous.  A quick internet search will turn up dozens of treatment centers around the world providing adult stem cell therapy.  

And that's a problem, according to Dr. Arthur Caplan, who recently wrote on this topic in an op ed appearing on the MSNBC website entitled "Stem Cells Clinics Ripping Off Patients and Bullying Scientists."

Caplan (whose honorific is for a Ph.D, not an MD) insists (without citing any scientific or other expert sources)
"Stem cell transplants of any sort -- outside of bone marrow transplants and a few other rarely used treatments -- are not anywhere close to being ready for therapeutic use...You would never know this if you looked at the nonsense that is all over the Internet about the power of stem cell "cures".
Caplan has some reason to be suspicious.  As the 60 Minutes  program 21st Century Snake Oil made clear, the efficacy and safety of adult autologous stem cell treatment does not extend to all stem cell treatment providers.  In the 60 Minutes story, reporter Scott Pelley uses hidden cameras to expose medical con men (working without a medical license) that prey on dying patients by using pitches that capitalize on the promise of stem cells.

Caveat Emptor and ICMS
In response to the proliferation of providers and the Wild West nature of the internet, where credibility verification can be difficult, oversight and regulatory bodies are beginning to exert their muscle.  Non-profit International Cellular Medicine Society (ICMS) began an offshore registry of stem cell treatment providers, and oversees an accreditation program ensuring all adult stem cell treatment centers have legitimate, science-based, registered clinical protocols as well as patient safety and efficacy measures in place.

The ICMS acts as a kind of industry watchdog for adult stem cell treatment , issuing this open letter addressing stem cell treatment proliferation, as well as publishing online patient guides like this Stem Cells 101 resource, and working directly with the health officials of countries where hospitals are providing treatment.

Among some of the recommendations given to patients: work with JCI-accredited medical facilities, work with treatment centers that have US medical research/university affiliations (for example, the Regenerative Medicine Institute at Hospital Angeles is voluntarily monitored by an Academic Advisory Committee that includes surgeons and research scientists from Duke University's Clinical Research Institute, Columbia University, and BioHeart), and ensure all treatments are administered by a board-certified specialist.

Related Articles